These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 14237449)

  • 21. [THE SOLUBILITY OF FIBRIN DEPOSITS].
    HEY D; BENEKE G
    Verh Dtsch Ges Pathol; 1963; 47():232-4. PubMed ID: 14168358
    [No Abstract]   [Full Text] [Related]  

  • 22. CURRENT STATUS OF THROMBOLYTIC THERAPY.
    SHERRY S
    Geriatrics; 1964 Sep; 19():628-43. PubMed ID: 14221883
    [No Abstract]   [Full Text] [Related]  

  • 23. ACTION OF THE NEW ANTI-FIBRINOLYTIC SUBSTANCE ON THE STREPTOKINASE-ACTIVATED PROTEASES (PLASMINS).
    MIHARA H
    Kobe J Med Sci; 1963 Dec; 18():169-77. PubMed ID: 14160537
    [No Abstract]   [Full Text] [Related]  

  • 24. THE EFFECT OF ATROMID-S ON THE FIBRINOLYTIC ENZYME SYSTEM.
    SWEET B; RIFKIND BM; MCNICOL GP
    J Atheroscler Res; 1965; 5(3):347-50. PubMed ID: 14290298
    [No Abstract]   [Full Text] [Related]  

  • 25. INVESTIGATIONS ON THE INHIBITORS OF THE FIBRINOLYTIC SYSTEM.
    DE WIT CD
    Thromb Diath Haemorrh; 1964 Oct; 12():105-18. PubMed ID: 14224627
    [No Abstract]   [Full Text] [Related]  

  • 26. [FIBRINOLYSIS INHIBITORS AND DETERMINATION OF PHYSIOLOGICAL AND PATHOLOGICAL ANTIPLASMIN ACTIVITY].
    MORIAU M; DE VRIES SI; DIK HJ
    Thromb Diath Haemorrh; 1964 Jan; 10():355-78. PubMed ID: 14113376
    [No Abstract]   [Full Text] [Related]  

  • 27. In vivro studies on fibrinogenolysis induced by streptokinase.
    GODAL HC; HELLE I
    Scand J Clin Lab Invest; 1963; 15():303-10. PubMed ID: 13963230
    [No Abstract]   [Full Text] [Related]  

  • 28. ON THE SUBSTRATE CHARACTERISTICS OF 5-HYDROXYTRYPTAMINE-CERULOPLASMIN TREATED HUMAN FIBRIN EXPOSED TO FIBRINOLYTIC AGENTS.
    AUERSWALD W; BERNHEIMER H; DOLESCHEL W
    Med Pharmacol Exp Int J Exp Med; 1965; 12():81-91. PubMed ID: 14279888
    [No Abstract]   [Full Text] [Related]  

  • 29. [TECHNIC FOR THE PREPARATION OF A FIBRINOGEN REAGENT FOR DETERMINATIONS OF FIBRINOLYTIC ACTIVITY].
    BLATRIX C; VIGNAL A; STEINBUCH M
    Hemostase; 1963; 3():179-86. PubMed ID: 14050814
    [No Abstract]   [Full Text] [Related]  

  • 30. THROMBOLYTIC THERAPY.
    FLUTE PT
    J Clin Pathol; 1964 May; 17(3):333-5. PubMed ID: 14159475
    [No Abstract]   [Full Text] [Related]  

  • 31. IN VIVO ACTIVATION OF THE FIBRINOLYTIC SYSTEM OF THE CAT. EFFECT OF STREPTOKINASE, TRYPSIN AND GLYCEROL.
    FLEMING LB; CLIFFTON EE
    J Surg Res; 1965 Apr; 5():153-65. PubMed ID: 14279210
    [No Abstract]   [Full Text] [Related]  

  • 32. [60 YEARS OF FIBRINOLYSIS].
    MARCHAL G
    Hemostase; 1963; 3():101-4. PubMed ID: 14050807
    [No Abstract]   [Full Text] [Related]  

  • 33. SOME PROPERTIES OF THE ANTIFIBRINOLYTICALLY ACTIVE ISOMER OF AMINO-METHYLCYCLOHEXANE CARBOXYLIC ACID.
    DUBBER AH; MCNICOL GP; DOUGLAS AS; MELANDER B
    Lancet; 1964 Dec; 2(7373):1317-9. PubMed ID: 14224037
    [No Abstract]   [Full Text] [Related]  

  • 34. THE ROLE OF FIBRINOLYSIS IN THE TREATMENT OF ARTERIAL THROMBOSIS: EXPERIMENTAL AND CLINICAL ASPECTS.
    TSAPOGAS MJ
    Ann R Coll Surg Engl; 1964 May; 34(5):293-313. PubMed ID: 14145330
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical and pathological studies: thrombolytic activity and related phenomena.
    VERSTRAETE M
    Thromb Diath Haemorrh; 1961; 6(Suppl 1)():328-9. PubMed ID: 13996899
    [No Abstract]   [Full Text] [Related]  

  • 36. VARIABILITY OF THE ANTICOAGULANT FRACTION OF INCUBATED FIBRINOGEN.
    TRIANTAPHYLLOPOULOS E; TRIANTAPHYLLOPOULOS DC
    Am J Physiol; 1965 Mar; 208():521-7. PubMed ID: 14264744
    [No Abstract]   [Full Text] [Related]  

  • 37. [Research on fibrinolysis: the fibrinolysis factors in Kline's plasminogen].
    GIACOMAZZI G
    Haematol Lat; 1961; 4():339-70. PubMed ID: 13898267
    [No Abstract]   [Full Text] [Related]  

  • 38. THE FIBRINOLYTIC SYSTEM DURING THE MENSTRUAL CYCLE.
    BELLER FK; GOEBELSMANN U; DOUGLAS GW; JOHNSON A
    Obstet Gynecol; 1964 Jan; 23():12-6. PubMed ID: 14110046
    [No Abstract]   [Full Text] [Related]  

  • 39. INHIBITION OF FIBRINOLYSIS AND FIBRINOGENOLYSIS IN MAN: COMPARISON OF EPILSON-AMINOCAPROIC AID AND KALLIKREIN INHIBITOR.
    BECK E; SCHMUTZLER R; DUCKERT F
    Thromb Diath Haemorrh; 1963 Nov; 10():106-19. PubMed ID: 14081273
    [No Abstract]   [Full Text] [Related]  

  • 40. [RESEARCH ON THE ENZYMATIC ACTIVITIES OF PLASMIN AND STREPTOKINASE].
    VAUXSAINT CYR
    Biol Med (Paris); 1963; 52():611-30. PubMed ID: 14095161
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.